SCHEMBL27915568

SCHEMBL27915568

COc1cc(OC)cc(-c2ncoc2-c2ccc(OC)c(F)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CYP17A1 P05093 1/20 0.42
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ MAPK14 Q16539 4/20 0.41
▸ TUBB4A P04350 1/20 0.41
▸ TUBB P07437 1/20 0.41
▸ TUBA3C P0DPH7 1/20 0.41
▸ TUBA1B P68363 1/20 0.41
▸ TUBA4A P68366 1/20 0.41
▸ TUBB4B P68371 1/20 0.41
▸ TUBB3 Q13509 1/20 0.41
▸ TUBB2A Q13885 1/20 0.41
▸ TUBB8 Q3ZCM7 1/20 0.41
▸ TUBA3E Q6PEY2 1/20 0.41
▸ TUBA1A Q71U36 1/20 0.41
▸ TUBA1C Q9BQE3 1/20 0.41
▸ TUBB6 Q9BUF5 1/20 0.41
▸ TUBB2B Q9BVA1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27820751 0.95 GSK3B (0.44) GSK3BCDK2CYP17A1MAPK14TUBB4A
SCHEMBL27820756 0.91 GSK3B (0.47) GSK3BCDK2CYP17A1HDAC1HDAC6
SCHEMBL28807093 0.88 HDAC1 (0.48) HDAC1HDAC6TUBB4ATUBBTUBA3C
SCHEMBL15664662 0.87 TUBB4A (0.55) GSK3BCDK2CYP17A1HDAC1HDAC6
SCHEMBL27820749 0.86 GSK3B (0.48) GSK3BCDK2CYP17A1HDAC1HDAC6
SCHEMBL15665220 0.86 GSK3B (0.48) GSK3BCDK2CYP17A1HDAC1HDAC6
SCHEMBL15665361 0.86 GSK3B (0.46) GSK3BCDK2CYP17A1HDAC1HDAC6
SCHEMBL15664738 0.84 DPP4 (0.46) HDAC1HDAC6TUBB4ATUBBTUBA3C
SCHEMBL15664335 0.84 ALDH1A1 (0.43) HDAC1HDAC6TUBB4ATUBBTUBA3C
SCHEMBL15665191 0.84 MAPK14 (0.39) GSK3BCDK2HDAC1HDAC6MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102863388-B Tumor targeted drug Combretastatin A4 derivatives NANJING SANHOME PHARMACEUTICAL CO LTD 2015-04-29 — — CN claimed
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 — — CN claimed
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 — — CN disclosed
Send feedback